{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:57:51Z","timestamp":1794221871962,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To review the utilization of bowel resection in ovarian cancer surgery in our institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All ovarian cancer patients who received bowel resection between 2006\/01 and 2018\/12 were identified. Postoperative morbidities were assessed according to the Clavien\u2013Dindo classification (CDC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 182 patients in the anastomosis group and 100 patients in the ostomy group, yielding a total of 282 patients. The median age was 57\u00a0years, and most patients had high-grade serous histology (88.7%). Forty-nine (17.3%) patients received neoadjuvant chemotherapy. During the operation, 78.7% of patients had ascites, and the median volume was 800\u00a0mL. Extensive bowel resection (at least two-segment) and upper abdominal operation were performed in 29 (10.2%) and 69 (24.4%) patients, respectively. The rectosigmoid colon was the most commonly resected (83.8%) followed by right hemicolectomy (5.9%) and small bowel resection (2.8%). No macroscopic residual disease was observed in 42.9% of the patients, whereas 87.9% had residual disease\u2009\u2264\u20091\u00a0cm. Among the entire cohort, 23.0% (65\/282) experienced different complications. Severe complications (CDC 3\u20135) accounted for 9.2% of complications and were mostly categorized as pleural effusion requiring drainage (3.5%) followed by wound dehiscence requiring delayed repair in the operating room (1.8%). Nine patients experienced anastomotic leakage (AL): one in the ostomy group with extensive bowel resection and eight in the anastomosis group. The overall AL rate was 4.2% (9\/212) per anastomosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The execution of bowel resection as part of debulking surgery in patients with newly diagnosed ovarian cancer resulted in a severe morbidity rate of 9.2%.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-022-01531-0","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:38:34Z","timestamp":1646383114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Shuang","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"1531_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1531_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer. 2009;115:1234\u201344.","journal-title":"Cancer"},{"key":"1531_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","volume":"59","author":"A Fagotti","year":"2016","unstructured":"Fagotti A, Ferrandina G, Vizzielli G, Fanfani F, Gallotta V, Chiantera V, Costantini B, Margariti PA, Gueli AS, Cosentino F, Tortorella L, Scambia G. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome. Eur J Cancer (Oxford, England\u202f: 1990). 2016;59:22\u201333.","journal-title":"Eur J Cancer (Oxford, England : 1990)."},{"key":"1531_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.21037\/gs-20-326","volume":"9","author":"VA Capozzi","year":"2020","unstructured":"Capozzi VA, Rosati A, Turco LC, Sozzi G, Ricc\u00f2 M, Chiofalo B, Vizzielli G. Surgery vs chemotherapy for ovarian cancer recurrence: what is the best treatment option. Gland Surg. 2020;9:1112\u20137.","journal-title":"Gland Surg"},{"key":"1531_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.semcancer.2021.02.009","volume":"77","author":"M Petrillo","year":"2021","unstructured":"Petrillo M, Sozzi G, Dessole M, Capobianco G, Dessole S, Madonia M, Cherchi PL, Paoletti AM, Scambia G, Chiantera V. The role of surgery in platinum-resistant ovarian cancer: a call to the scientific community. Semin Cancer Biol. 2021;77:194\u2013202.","journal-title":"Semin Cancer Biol"},{"key":"1531_CR6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e3","volume":"31","author":"K Nishikimi","year":"2020","unstructured":"Nishikimi K, Tate S, Kato K, Matsuoka A, Shozu M. Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely. J Gynecol Oncol. 2020;31: e3.","journal-title":"J Gynecol Oncol."},{"key":"1531_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12885-015-1525-1","volume":"15","author":"Y Ren","year":"2015","unstructured":"Ren Y, Jiang R, Yin S, You C, Liu D, Cheng X, Tang J, Zang R. Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study. BMC Cancer. 2015;15:583.","journal-title":"BMC Cancer"},{"key":"1531_CR8","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2016.27.e62","volume":"27","author":"L Xiang","year":"2016","unstructured":"Xiang L, Tu Y, He T, Shen X, Li Z, Wu X, Yang H. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer. J Gynecol Oncol. 2016;27: e62.","journal-title":"J Gynecol Oncol."},{"key":"1531_CR9","first-page":"629","volume":"27","author":"XW Ziting","year":"2004","unstructured":"Ziting XW, Li GZ, Zhu H, Fang Y, Zhou Y, Huang X, Zhang Z. Low colorectal staple anastomosis after radical pelvic surgery for gynecologic malignancies. Shanghai Med J. 2004;27:629\u201332.","journal-title":"Shanghai Med J"},{"key":"1531_CR10","first-page":"430","volume":"22","author":"JTD Liu","year":"2012","unstructured":"Liu JTD, Zang R, Li Z, Xiaohua Wu. Modified posterior pelvic exenteration in primary cytoreductive surgery for epithelial ovarian cancer. China Oncol. 2012;22:430\u20135.","journal-title":"China Oncol"},{"key":"1531_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","volume":"119","author":"DS Chi","year":"2010","unstructured":"Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, Gardner GJ, Leitao MM Jr, Levine DA, Sonoda Y, Abu-Rustum NR, Brown CL, Barakat RR. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010;119:38\u201342.","journal-title":"Gynecol Oncol"},{"key":"1531_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygyno.2010.07.032","volume":"119","author":"M Peiretti","year":"2010","unstructured":"Peiretti M, Zanagnolo V, Aletti GD, Bocciolone L, Colombo N, Landoni F, Minig L, Biffi R, Radice D, Maggioni A. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. Single institution experience. Gynecol Oncol. 2010;119:259\u201364.","journal-title":"Gynecol Oncol"},{"key":"1531_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ygyno.2015.05.010","volume":"138","author":"R Tozzi","year":"2015","unstructured":"Tozzi R, Giannice R, Cianci S, Tardino S, Campanile RG, Gubbala K, Fachechi G, Ferrari F, Martinek I, Soleymani MH. Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecol Oncol. 2015;138:252\u20138.","journal-title":"Gynecol Oncol"},{"key":"1531_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tjog.2016.04.010","volume":"55","author":"R Berretta","year":"2016","unstructured":"Berretta R, Marchesi F, Volpi L, Ricotta G, Monica M, Sozzi G, Di Serio M, Mautone D. Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: clinical and functional outcome. Taiwan J Obstet Gynecol. 2016;55:346\u201350.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1531_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ygyno.2016.05.035","volume":"142","author":"JH Tseng","year":"2016","unstructured":"Tseng JH, Suidan RS, Zivanovic O, Gardner GJ, Sonoda Y, Levine DA, Abu-Rustum NR, Tew WP, Chi DS, Long RK. Diverting ileostomy during primary debulking surgery for ovarian cancer: associated factors and postoperative outcomes. Gynecol Oncol. 2016;142:217\u201324.","journal-title":"Gynecol Oncol"},{"key":"1531_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ygyno.2017.06.007","volume":"146","author":"C Grimm","year":"2017","unstructured":"Grimm C, Harter P, Alesina PF, Prader S, Schneider S, Ataseven B, Meier B, Brunkhorst V, Hinrichs J, Kurzeder C, Heitz F, Kahl A, Traut A, Groeben HT, Walz M, du Bois A. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery. Gynecol Oncol. 2017;146:498\u2013503.","journal-title":"Gynecol Oncol"},{"key":"1531_CR17","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1097\/IGC.0000000000001369","volume":"28","author":"T Bartl","year":"2018","unstructured":"Bartl T, Schwameis R, Stift A, Bachleitner-Hofmann T, Reinthaller A, Grimm C, Polterauer S. Predictive and prognostic implication of bowel resections during primary cytoreductive surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2018;28:1664\u201371.","journal-title":"Int J Gynecol Cancer"},{"key":"1531_CR18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00404-018-4675-y","volume":"297","author":"R Berretta","year":"2018","unstructured":"Berretta R, Capozzi VA, Sozzi G, Volpi L, Ceni V, Melpignano M, Giordano G, Marchesi F, Monica M, Di Serio M, Ricc\u00f2 M, Ceccaroni M. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer. Arch Gynecol Obstet. 2018;297:997\u20131004.","journal-title":"Arch Gynecol Obstet"},{"key":"1531_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ygyno.2019.03.241","volume":"153","author":"V Lago","year":"2019","unstructured":"Lago V, Fotopoulou C, Chiantera V, Minig L, Gil-Moreno A, Cascales-Campos PA, Jurado M, Tejerizo A, Padilla-Iserte P, Malune ME, Di Donna MC, Marina T, Sanchez-Iglesias JL, Olloqui A, Garcia-Granero A, Matute L, Fornes V, Domingo S. Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: a multi-centre study. Gynecol Oncol. 2019;153:549\u201354.","journal-title":"Gynecol Oncol"},{"key":"1531_CR20","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ygyno.2008.07.053","volume":"111","author":"SM Kehoe","year":"2008","unstructured":"Kehoe SM, Eisenhauer EL, Chi DS. Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy\/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol. 2008;111:S51\u20135.","journal-title":"Gynecol Oncol"},{"key":"1531_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00404-020-05684-2","volume":"302","author":"G Sozzi","year":"2020","unstructured":"Sozzi G, Petrillo M, Berretta R, Capozzi VA, Paci G, Music\u00f2 G, Di Donna MC, Vargiu V, Bernardini F, Lago V, Domingo S, Fagotti A, Scambia G, Chiantera V. Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience. Arch Gynecol Obstet. 2020;302:707\u201314.","journal-title":"Arch Gynecol Obstet"},{"key":"1531_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/jso.25403","volume":"119","author":"JH Son","year":"2019","unstructured":"Son JH, Kong TW, Paek J, Chang SJ, Ryu HS. Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer. J Surg Oncol. 2019;119:1011\u20135.","journal-title":"J Surg Oncol"},{"key":"1531_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"1531_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ygyno.2015.07.005","volume":"138","author":"B Ataseven","year":"2015","unstructured":"Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, Prader S, Polterauer S, Harter P, Grimm C. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015;138:560\u20135.","journal-title":"Gynecol Oncol"},{"key":"1531_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ejso.2020.09.014","volume":"47","author":"AC Vito","year":"2021","unstructured":"Vito AC, Uccella S, Sozzi G, Ceccaroni M, Mautone D, Armano G, Franchi M, Chiantera V, Berretta R. Primary site disease and recurrence location in ovarian cancer patients undergoing primary debulking surgery vs interval debulking surgery. Eur J Surg Oncol. 2021;47:1075\u201382.","journal-title":"Eur J Surg Oncol"},{"key":"1531_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1006\/gyno.2001.6375","volume":"83","author":"W Jaeger","year":"2001","unstructured":"Jaeger W, Ackermann S, Kessler H, Katalinic A, Lang N. The effect of bowel resection on survival in advanced epithelial ovarian cancer. Gynecol Oncol. 2001;83:286\u201391.","journal-title":"Gynecol Oncol"},{"key":"1531_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/ijgc-2020-001243","volume":"30","author":"JA Dottino","year":"2020","unstructured":"Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020;30:1195\u2013202.","journal-title":"Int J Gynecol Cancer"},{"key":"1531_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ygyno.2012.04.030","volume":"126","author":"M Peiretti","year":"2012","unstructured":"Peiretti M, Bristow RE, Zapardiel I, Gerardi M, Zanagnolo V, Biffi R, Landoni F, Bocciolone L, Aletti GD, Maggioni A. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. Gynecol Oncol. 2012;126:220\u20133.","journal-title":"Gynecol Oncol"},{"key":"1531_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.06.504","author":"L Bernard","year":"2020","unstructured":"Bernard L, Boucher J, Helpman L. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: an ACS-NSQIP study. Gynecol Oncol. 2020. https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.504.","journal-title":"Gynecol Oncol"},{"key":"1531_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ejso.2018.01.005","volume":"44","author":"M Fournier","year":"2018","unstructured":"Fournier M, Huchon C, Ngo C, Bensaid C, Bats AS, Combe P, le FrereBelda MA, Fournier L, Berger A, Lecuru F. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis. Eur J Surg Oncol. 2018;44:750\u20133.","journal-title":"Eur J Surg Oncol"},{"key":"1531_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ygyno.2013.04.002","volume":"130","author":"E Kalogera","year":"2013","unstructured":"Kalogera E, Dowdy SC, Mariani A, Weaver AL, Aletti G, Bakkum-Gamez JN, Cliby WA. Multiple large bowel resections: potential risk factor for anastomotic leak. Gynecol Oncol. 2013;130:213\u20138.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-022-01531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-022-01531-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-022-01531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:45:06Z","timestamp":1646383506000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-022-01531-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1186\/s12893-022-01531-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-21911\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board at Fudan University Shanghai Cancer Center. The requirement for written informed consent was waived due to the retrospective design. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors have nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}